JP2016519138A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519138A5
JP2016519138A5 JP2016512345A JP2016512345A JP2016519138A5 JP 2016519138 A5 JP2016519138 A5 JP 2016519138A5 JP 2016512345 A JP2016512345 A JP 2016512345A JP 2016512345 A JP2016512345 A JP 2016512345A JP 2016519138 A5 JP2016519138 A5 JP 2016519138A5
Authority
JP
Japan
Prior art keywords
pain
protein
tafa4
seq
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016512345A
Other languages
English (en)
Japanese (ja)
Other versions
JP6487419B2 (ja
JP2016519138A (ja
Filing date
Publication date
Priority claimed from EP13305592.1A external-priority patent/EP2801369A1/en
Application filed filed Critical
Publication of JP2016519138A publication Critical patent/JP2016519138A/ja
Publication of JP2016519138A5 publication Critical patent/JP2016519138A5/ja
Application granted granted Critical
Publication of JP6487419B2 publication Critical patent/JP6487419B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016512345A 2013-05-06 2014-05-06 Tafa4化合物及び疼痛を処置するためのその使用 Active JP6487419B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305592.1A EP2801369A1 (en) 2013-05-06 2013-05-06 TAFA4 compounds and uses thereof for treating pain
EP13305592.1 2013-05-06
PCT/EP2014/059247 WO2014180853A1 (en) 2013-05-06 2014-05-06 Tafa4 compounds and uses thereof for treating pain

Publications (3)

Publication Number Publication Date
JP2016519138A JP2016519138A (ja) 2016-06-30
JP2016519138A5 true JP2016519138A5 (cg-RX-API-DMAC7.html) 2018-08-30
JP6487419B2 JP6487419B2 (ja) 2019-03-20

Family

ID=48428409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016512345A Active JP6487419B2 (ja) 2013-05-06 2014-05-06 Tafa4化合物及び疼痛を処置するためのその使用

Country Status (8)

Country Link
US (2) US9884088B2 (cg-RX-API-DMAC7.html)
EP (2) EP2801369A1 (cg-RX-API-DMAC7.html)
JP (1) JP6487419B2 (cg-RX-API-DMAC7.html)
CN (1) CN105209056B (cg-RX-API-DMAC7.html)
CA (2) CA2910652C (cg-RX-API-DMAC7.html)
DK (1) DK2994157T3 (cg-RX-API-DMAC7.html)
ES (1) ES2813629T3 (cg-RX-API-DMAC7.html)
WO (1) WO2014180853A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016147825A1 (ja) * 2015-03-13 2016-09-22 シスメックス株式会社 被検物質の検出方法およびその方法に用いられる試薬キット
WO2019089465A1 (en) * 2017-10-30 2019-05-09 The Regents Of The University Of California Calibration free in-vivo measurement of analytes using electrochemical sensors
CN119607195A (zh) * 2018-04-24 2025-03-14 纽洛可科学有限公司 抗序列相似家族19成员a5的抗体在治疗神经性疼痛中的用途
EP3856228B1 (en) * 2018-09-27 2023-03-08 Institut National de la Santé et de la Recherche Médicale (INSERM) Tafa4 polypeptide for use for reducing skin inflammation
CN109596818B (zh) * 2018-12-13 2024-03-19 丁蓉 一种基于电生理学分析当归四逆汤预防奥沙利铂神经毒性机制的研究方法
EP4100043A1 (en) * 2020-02-04 2022-12-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Tafa4 polypeptide or polynucleotide for treating inflammatory disease
WO2021163425A1 (en) * 2020-02-13 2021-08-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Margaric acid decreases piez02-mediated pain
CN118401249A (zh) 2021-12-17 2024-07-26 塔法吉斯生技公司 用于治疗疼痛的肽和方法
MX2024007794A (es) * 2021-12-20 2024-07-02 Amgen Inc Peptidos de union a dll3 y usos de los mismos.
AR129441A1 (es) 2022-05-25 2024-08-28 Tafalgie Therapeutics Péptidos y métodos para el tratamiento del dolor
AU2023278710A1 (en) * 2022-05-31 2024-12-12 Neuracle Genetics Inc. Composition for treating retinal or macular diseases
CN120813839A (zh) 2023-02-17 2025-10-17 Naos生命科学研究所 一种用于筛选能够提高皮肤耐受阈值的生态生物型化合物的方法
WO2025116606A1 (ko) * 2023-11-30 2025-06-05 주식회사 뉴라클제네틱스 신규한 케모카인-유사 단백질 단편

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090077680A1 (en) * 2000-06-12 2009-03-19 Alejandro Abuin Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same
US20090136552A1 (en) * 2004-07-30 2009-05-28 Mette Gronborg Growth factors nsg28, nsg30, and nsg32

Similar Documents

Publication Publication Date Title
JP2016519138A5 (cg-RX-API-DMAC7.html)
JP7379428B2 (ja) Nk細胞におけるサイトカイン誘導性sh2タンパク質の阻害
EP3371207B1 (en) Nucleic acids, peptides and methods
Park et al. Molecular cloning and functional analysis of nucleotide-binding oligomerization domain 1 (NOD1) in olive flounder, Paralichthys olivaceus
Baker et al. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders
US9107942B2 (en) Methods of diagnosing and treating fibrosis
Bathige et al. Interferon regulatory factors 4 and 8 in rock bream, Oplegnathus fasciatus: structural and expressional evidence for their antimicrobial role in teleosts
JP2019500414A5 (cg-RX-API-DMAC7.html)
Schnöder et al. Neuronal deficiency of p38α‐MAPK ameliorates symptoms and pathology of APP or Tau‐transgenic Alzheimer’s mouse models
JP2017533910A5 (cg-RX-API-DMAC7.html)
Hu et al. Interferon regulatory factor 3 (IRF-3) in Japanese flounder, Paralichthys olivaceus: sequencing, limited tissue distribution, inducible expression and induction of fish type I interferon promoter
US20200032210A1 (en) Natural killer cells
Sun et al. A short-type peptidoglycan recognition protein from tongue sole (Cynoglossus semilaevis) promotes phagocytosis and defense against bacterial infection
US11229679B2 (en) Compositions for treating heart disease by inhibiting the action of mAKAPβ
WO2019010301A1 (en) TREATMENT OF CARDIOPATHIES BY INHIBITING THE ACTION OF PROTEINS FROM ANCHORING TO MUSCLE PROTEIN KINASES A (MAKAP)
WO2009053683A2 (en) Treatment of inflammatory diseases
US20060154886A1 (en) Regulatory elements in the 5' region of the VR1 gene
JP5793188B2 (ja) 自己免疫疾患治療及び予防薬としてのctrp6
Oliveira Filho et al. Cloning, sequencing and expression analysis of the equine hepcidin gene by real-time PCR
Xiao et al. Cloning of common carp SOCS-3 gene and its expression during embryogenesis, GH-transgene and viral infection
JP2015523861A (ja) 制御された遺伝子発現方法
JP2016520570A (ja) A型インフルエンザウイルス感染の治療又は予防に使用するためのpar−4アンタゴニスト
Nam et al. Molecular cloning and characterization of LPS-binding protein/bactericidal permeability-increasing protein (LBP/BPI) from olive flounder, Paralichthys olivaceus
Atianand et al. Recent evolution of the NF-κB and inflammasome regulating protein POP2 in primates
CN112153897B (zh) 用于治疗神经病学和其他病症的组合物和方法